During week 2, bioluminescence imaging revealed a reduction in tumor size in 1/5 mice from the CD276 group and in 1/5 mice from the F8-FR4 group, compared to the controls (Fig. 14B, D). The gene discussed is CD276; the disease is neoplasm.